These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18157582)

  • 21. [Postoperative adjuvant treatment for pancreatic cancer].
    Uesaka K; Kanemoto H; Sugiura T; Mizuno T; Kinugasa Y; Bando E; Terashima M
    Nihon Geka Gakkai Zasshi; 2011 May; 112(3):187-90. PubMed ID: 21688463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of adjuvant therapy for pancreatic cancer.
    Magee CJ; Ghaneh P; Hartley M; Sutton R; Neoptolemos JP
    Expert Opin Investig Drugs; 2002 Jan; 11(1):87-107. PubMed ID: 11772324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant therapy for pancreatic cancer: back to the future.
    Regine WF; Abrams RA
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):59-63. PubMed ID: 9747820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resection and radiochemotherapy of pancreatic cancer--the future?
    Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
    Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
    Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
    Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).
    Neoptolemos JP; Baker P; Beger H; Link K; Pederzoli P; Bassi C; Dervenis C; Friess H; Büchler M
    Int J Pancreatol; 1997 Apr; 21(2):97-104. PubMed ID: 9209950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and controversies of adjuvant therapy for pancreatic cancer.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):121-5. PubMed ID: 18397844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy in pancreatic cancer.
    Ghaneh P; Slavin J; Sutton R; Hartley M; Neoptolemos JP
    World J Gastroenterol; 2001 Aug; 7(4):482-9. PubMed ID: 11819814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials.
    Kurreck A; Weckwerth J; Modest DP; Striefler JK; Bahra M; Bischoff S; Pelzer U; Oettle H; Kruger S; Riess H; Sinn M
    Eur J Cancer; 2021 Jun; 150():250-259. PubMed ID: 33940349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seminars in surgical oncology-Pancreas cancer adjuvant therapy trials.
    Essaji Y; Rocha FG
    J Surg Oncol; 2021 May; 123(6):1467-1474. PubMed ID: 33831255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.
    Smeenk HG; van Eijck CH; Hop WC; Erdmann J; Tran KC; Debois M; van Cutsem E; van Dekken H; Klinkenbijl JH; Jeekel J
    Ann Surg; 2007 Nov; 246(5):734-40. PubMed ID: 17968163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoradiation for pancreatic and biliary cancer: current status of RTOG studies.
    Rich TA
    Ann Oncol; 1999; 10 Suppl 4():231-3. PubMed ID: 10436829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
    Regine WF; Winter KA; Abrams R; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Rich TA; Willett CG
    Ann Surg Oncol; 2011 May; 18(5):1319-26. PubMed ID: 21499862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine.
    Baschnagel A; Shah C; Margolis J; Nadeau L; Stein J; Jury R; Robertson JM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e331-5. PubMed ID: 22420967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
    Oettle H; Neuhaus P; Hochhaus A; Hartmann JT; Gellert K; Ridwelski K; Niedergethmann M; Zülke C; Fahlke J; Arning MB; Sinn M; Hinke A; Riess H
    JAMA; 2013 Oct; 310(14):1473-81. PubMed ID: 24104372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant therapy in operable pancreatic cancer.
    Wente MN; Büchler P; Friess H; Büchler MW
    Swiss Surg; 2002; 8(2):74-80. PubMed ID: 12013694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy for pancreatic cancer: current status.
    Regine WF; John WJ; Mohiuddin M
    Front Biosci; 1998 Nov; 3():E186-92. PubMed ID: 9820740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients.
    Voong KR; Davison J; Pawlik TM; Uy MO; Hsu CC; Winter J; Hruban RH; Laheru D; Rudra S; Swartz MJ; Nathan H; Edil BH; Schulick R; Cameron JL; Wolfgang CL; Herman JM
    Hum Pathol; 2010 Jan; 41(1):113-22. PubMed ID: 19801164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
    Stocken DD; Büchler MW; Dervenis C; Bassi C; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Neoptolemos JP;
    Br J Cancer; 2005 Apr; 92(8):1372-81. PubMed ID: 15812554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
    Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
    Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.